Management characterizes the current phase as an 'inflection point' where the focus shifts from building AI models to translating them into tangible clinical evidence and measurable impact.

Cash Balance: Ended the year with $754 million in cash. Operating Expenses: 35% reduction in pro forma operating expenses year over year. 2026 Cash Operating Expenses: Expected to be under $390 ...

Recursion Pharmaceuticals reported its fourth-quarter 2025 earnings, showcasing a significant beat on both earnings and revenue forecasts. The company reported an EPS of -$0.21, surpassing the ...

TUCSON, Ariz. — One criminal expert said even though the investigation into Nancy Guthrie "isn't cold yet," the "best" forensic scientists should go into her house and "scrutinize" everything inside.

TOKYO: Toyota plans a large-scale unwinding of strategic shareholdings that would involve banks and insurance firms selling around US$19 billion of its shares, two sources said, in what would mark a ...